{"id":"NCT03678675","sponsor":"Tufts Medical Center","briefTitle":"Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial","officialTitle":"Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-05-30","primaryCompletion":"2022-01-31","completion":"2022-06-30","firstPosted":"2018-09-19","resultsPosted":"2022-08-18","lastUpdate":"2022-08-18"},"enrollment":148,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Post-operative Pain","Post-partum Pain","Cesarean Section Complications"],"interventions":[{"type":"DRUG","name":"Ketorolac","otherNames":[]}],"arms":[{"label":"Standard Protocol","type":"NO_INTERVENTION"},{"label":"Ketorolac Protocol","type":"EXPERIMENTAL"}],"summary":"To evaluate the efficacy of increased ketorolac in reducing opioid use after cesarean section.","primaryOutcome":{"measure":"The Total Morphine Milligram Equivalents (MME) Used in the First 72 Postoperative Hours","timeFrame":"Within 72 postoperative hours","effectByArm":[{"arm":"Standard Protocol","deltaMin":60,"sd":null},{"arm":"Ketorolac Protocol","deltaMin":30,"sd":null}],"pValues":[]},"eligibility":{"minAge":"16 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":9},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["36897140"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":74},"commonTop":[]}}